We provide 1 form of Pretomanid
Pretomanid
187235-37-6
|
359.073
|
2.792
Pretomanid kills the actively replicating bacteria causing tuberculosis, known as Mycobacterium tuberculosis, and shortens the duration of treatment in patients who suffer from resistant forms of pulmonary TB by killing dormant bacteria. Pretomanid is indicated for adults in combination with bedaquiline and linezolid for the treatment of pulmonary forms of nonresponsive multidrug-resistant, extensively drug-resistant, and treatment-intolerant forms of pulmonary tuberculosis.
(S)-PA-824 | MMV688755 | PA-824 | pretomanid
Pretomanid kills the actively replicating bacteria causing tuberculosis, known as Mycobacterium tuberculosis, and shortens the duration of treatment in patients who suffer from resistant forms of pulmonary TB by killing dormant bacteria. Pretomanid is indicated for adults in combination with bedaquiline and linezolid for the treatment of pulmonary forms of nonresponsive multidrug-resistant, extensively drug-resistant, and treatment-intolerant forms of pulmonary tuberculosis.
(S)-PA-824 | MMV688755 | PA-824 | pretomanid
$89/5 mg
(EBC)
1
We provide 0 compound for Pretomanid